Pluronic F127 nanoparticles modified with folate and loaded with phycocyanobilin for tumor-targeted photodynamic therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
2. Light-responsive nanomaterials for cancer therapy
3. Emerging combination strategies with phototherapy in cancer nanomedicine10.1039/D0CS00215A ↗
4. A multifunctional hyaluronic acid-engineered mesoporous nanoreactor with H2O2/O2 self-sufficiency for pH-triggered endo-lysosomal escape and synergetic cancer therapy10.1016/j.bioadv.2024.214161 ↗
5. Tumor microenvironment activated mussel-inspired hollow mesoporous nanotheranostic for enhanced synergistic photodynamic/chemodynamic therapy10.1016/j.jcis.2024.03.133 ↗
6. Intelligent triggering of nanomicelles based on a ROS-activated anticancer prodrug and photodynamic therapy (PDT)-synergistic therapy for lung cancers10.1016/j.ejmech.2022.114622 ↗
7. Smart molecular designs and applications of activatable organic photosensitizers10.1038/s41570-024-00662-7 ↗
8. A photoswitchable antimetabolite for targeted photoactivated chemotherapy10.1021/jacs.8b08249 ↗
9. Fe (III)-coordination-driven fabrication of self-supplying oxygen and charge-convertible nanoplatform for enhanced photodynamic therapy of tumor10.1016/j.eurpolymj.2023.112130 ↗
10. Oxygen-generating organic/inorganic self-assembled nanocolloids for tumor-activated dual-model imaging-guided photodynamic therapy10.1021/acsami.3c07008 ↗
11. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
12. Porphyrin-xylan-coated silica nanoparticles for anticancer photodynamic therapy10.1016/j.carbpol.2019.02.070 ↗
13. Photodynamic therapy-mechanisms, photosensitizers and combinations10.1016/j.biopha.2018.07.049 ↗
14. Advances in photosensitizer-related design for photodynamic therapy
15. Photodynamic therapy: past, present and future10.1002/tcr.201600121 ↗
16. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
17. Asymmetric, amphiphilic rgd conjugated phthalocyanine for targeted photodynamic therapy of triple negative breast cancer10.1038/s41392-022-00906-2 ↗
18. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
19. Self-assembled nano-photosensitizer for targeted, activatable, and biosafe cancer phototheranostics10.1016/j.biomaterials.2022.121916 ↗
20. C-phycocyanin as a tumour-associated macrophage-targeted photosensitizer and a vehicle of phthalocyanine for enhanced photodynamic therapy10.1039/C6CC09541K ↗
21. Phycocyanobilin from arthrospira platensis: a potential photodynamic anticancer agent10.1016/j.dyepig.2023.111516 ↗
22. Nanotherapeutics to overcome conventional cancer chemotherapy limitation s
23. Nano-drug delivery systems based on natural products10.2147/IJN.S443692 ↗
24. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial10.1001/jama.286.17.2099 ↗
25. Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma10.1096/fj.05-4024fje ↗
26. Folic acid-targeted pluronic f127 micelles improve oxidative stress and inhibit fibrosis for increasing aki efficacy10.1016/j.ejphar.2022.175131 ↗
27. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy10.1016/j.drudis.2020.12.006 ↗
28. Macromolecular design of folic acid functionalized amylopectin-albumin core-shell nanogels for improved physiological stability and colon cancer cell targeted delivery of curcumin10.1016/j.jcis.2020.07.056 ↗
29. Reactive oxygen species (Ros)-response nanomedicine through knocking down a novel therapeutic target nedd8-conjugating enzyme ubc12 (ube2m) in the treatment of liver cancer10.1016/j.matdes.2021.109648 ↗
30. Pluronic f127-folate coated super paramagenic iron oxide nanoparticles as contrast agent for cancer diagnosis in magnetic resonance imaging10.3390/polym11040743 ↗
31. Folic acid functionalized aggregation-induced emission nanoparticles for tumor cell targeted imaging and photodynamic therapy
32. The new zinc phthalocyanine having high singlet oxygen quantum yield substituted with new benzenesulfonamide derivative groups containing schiff base10.1016/j.molstruc.2019.127181 ↗
33. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and ph-triggered drug releasing properties for active intracellular drug delivery10.1039/B500266D ↗
34. Recent progress in biomedical applications of pluronic (pf127): pharmaceutical perspectives10.1016/j.jconrel.2015.04.032 ↗
35. Single-wall carbon nanotube-ferrocene nanohybrids: observing intramolecular electron transfer in functionalized swnts10.1002/anie.200351289 ↗
36. Perfluorocarbon-loaded and redox-activatable photosensitizing agent with oxygen supply for enhancement of fluorescence/photoacoustic imaging guided tumor photodynamic therapy10.1002/adfm.201806199 ↗
37. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method10.3390/molecules25204781 ↗
38. Influence of solvent evaporation technique parameters on diameter of submicron lamivudine-poly-epsilon-caprolactone conjugate particles10.3390/nano9091240 ↗
39. Overview of the blood compatibility of nanomedicines: a trend analysis of in vitro and in vivo studie s10.1002/wnan.1546 ↗
40. Main trends of immune effects triggered by nanomedicines in preclinical studies10.2147/IJN.S168808 ↗
41. The development of 1,3-diphenylisobenzofuran as a highly selective probe for the detection and quantitative determination of hydrogen peroxide10.1080/10715762.2016.1262541 ↗
42. Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases10.3389/fimmu.2021.703972 ↗
43. Cellular uptake and apoptotic properties of gemini curcumin in gastric cancer cells10.1007/s11033-021-06713-2 ↗
44. Dinuclear phosphorescent rhenium(i) complexes as potential anticancer and photodynamic therapy agents10.1039/D0DT02424D ↗
45. Hybrid tio(2) -ruthenium nano-photosensitizer synergistically produces reactive oxygen species in both hypoxic and normoxic conditions10.1002/anie.201704458 ↗
46. Fluorinated pyrazoline-linked axial silicon phthalocyanine, alpha (α) and beta (β) zinc phthalocyanines on photophysicochemical properties10.1016/j.ica.2023.121480 ↗
47. Therapeutic index improvement of antibody-drug conjugates10.1080/19420862.2023.2230618 ↗
48. Towards cheminformatics-based estimation of drug therapeutic index: predicting the protective index of anticonvulsants using a new quantitative structure-index relationship approach10.1016/j.jmgm.2016.05.006 ↗
49. Tumor site-specific peg detachment and active tumor homing of therapeutic pegylated chitosan/folate-decorated polydopamine nanoparticles to augment antitumor efficacy of photothermal/chemo combination therapy10.1016/j.cej.2022.137243 ↗
50. The bioactivities of phycocyanobilin from spirulina
51. Ganoderic acid A alleviates OVA-induced asthma in mice10.1007/s10753-021-01468-1 ↗